More Videos
- Readers Get Short With Me--Over Amgen
- Biopharma Analyst Musical Chairs
- Abbott, Boston Scientific Stents & Stuff
- A "Short" Story On Amgen
- Merck Muscles In On Migraines
- Boston Scientific: Hurry To The Pre-4th of July Sale On Stents!?
- Credit Suisse Healthier 15: Investors Get Skinny On Fat Fighters
- FDA Delivers One-Two Punch To Merck & Lilly
- Lilly's Effient Empire
- Pfizer and the State of Statins
- Bowyer: Back to Monarchy in Land Rights?
- Parking Cash in European Telecoms
- Bargain Stocks: Nokia, Spectra, Incitex Pivot
- Sticker Shock: Fast Money's Inflation Special
- Our Favorite Inflation Trades
- Warren Buffett's Annual Stock Gift to Gates Foundation Worth $1.8B This Year
- That '70's Trade
- The Villain Of Our Story
- The Blame Game
- EU Opens Probe in BHP Billiton Bid for Rio Tinto
- Worse Car Sales Decline Expected in Western Europe
- Euro Banks Need to Raise $90-$140 Billion: Goldman
- BSkyB Mulls $4 Billion Bid for Spain's Digital Plus: FT
- On the Bright Side, Shopping Bargains Abound
- Euro Stocks Fall as Goldman Note Hits Banks
- Return of Asian Currency Crisis Is Unlikely: ADB
- European Shares Set to Open Flat as Holiday Shuts US
- Airbus to Sell Five A380s to Japan's ANA: Nikkei
 |
CNBC.com |
] management at the start of the Q and A portion of the biotech company's analyst meeting? Yep. Mark Schoenebaum from Bear Stearns [BSC
Loading...
()
]. When they get the mike, the analysts all state their names and the firms they work for. And as soon as Schoenebaum said, "Bear Stearns", Genentech CEO Art Levinson yells out, "You mean there's somebody from Bear Stearns still here?" The room erupted in laughter.
related content |
Schoenebaum came back with a quick retort, "You guys (the Genentech team) do great work," jokingly hinting he might need to butter them up for a job soon. Genentech's CFO, David Ebersman, used to be a sell-side analyst. By the way, I'll be doing a "First On CNBC" interview with Ebersman on "Closing Bell" at 3 p.m. ET today.
And then toward the end of the Q and A session an analyst gets the mike and once again prefaces his question by introducing himself, "Geoffrey Meacham with JPMorgan...soon to be the parent company, I guess, of Bear Stearns."
Laughter ensues. The meeting ends.
Questions? Comments?
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes